The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
The University of Texas Health Science Center at Houston, Houston, TX, USA.
Leuk Lymphoma. 2021 Sep;62(9):2253-2260. doi: 10.1080/10428194.2021.1901096. Epub 2021 Mar 22.
There is growing Internet and social media use among patients with rare blood cancers, notably myeloproliferative neoplasms (MPNs). A 38-item online questionnaire was developed to assess patients' ( = 983) disease understanding and use of online resources regarding MPN. Many responders (74%) reported unawareness of additional mutations beyond their primary molecular marker(s); 32% were unsure of their prognostic risk stratification. Additionally, 89% reported using online resources (Facebook (61%); Google/Google+ (42%); YouTube (34%); blogs (26%); Twitter (5%)) to seek information about MPN. Despite this, results showed many gaps in patients' basic disease knowledge. Our findings suggest an important difference in social media habits between physicians and patients: physicians are rapidly adopting Twitter as their preferred medium for sharing medical knowledge; however, patients often prefer other social mediums. Educational campaigns should be designed in more personalized ways, aiming to fit a variety of online platforms to maximize reach and impact for patients with MPN.
越来越多患有罕见血液癌症(尤其是骨髓增殖性肿瘤)的患者开始使用互联网和社交媒体。我们开发了一份 38 项的在线问卷,以评估患者(=983 人)对 MPN 的疾病认知程度以及对在线资源的使用情况。许多受访者(74%)表示,他们并不知道除了主要分子标志物以外还有其他突变;32%的人不确定自己的预后风险分层。此外,89%的受访者表示曾使用在线资源(Facebook(61%);Google/Google+(42%);YouTube(34%);博客(26%);Twitter(5%))来获取有关 MPN 的信息。尽管如此,调查结果仍显示出患者在基本疾病知识方面存在许多空白。我们的研究结果表明,医生和患者在社交媒体习惯上存在重要差异:医生正在迅速采用 Twitter 作为分享医学知识的首选媒介;然而,患者通常更喜欢其他社交媒体。应该以更个性化的方式设计教育活动,旨在针对各种在线平台进行设计,以最大限度地提高 MPN 患者的覆盖范围和影响力。